Fig. 1 · Structure
Documents & Downloads
AO-1535
Monoglycosylceramide
AO-1535 is a semisynthetic monoglycosylceramide that targets the inhibition of reactive oxygen species production in human monocytes and macrophages in response to phorbol ester and chemotactic tetrapeptide stimulation. This compound exhibits anti-inflammatory properties and is valuable for research applications related to inflammatory dermatoses, offering insights into cellular oxidative stress mechanisms.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 87178-48-1 |
| Applications | Monoglycosylceramide |
| Formula | C30H50N2O8 |
| Molecular Weight | 566.73 |
| SMILES | O=C(N[C@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)CO[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)C2=CC=CN=C2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.